A simple and reproducible breast cancer prognostic test

BMC Genomics

Volumn 14, Issue 1, 2013, Pages

  Marchionni, Luigi ^a   Afsari, Bahman ^c   Geman, Donald ^c   Leek, Jeffrey T ^b,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Johns Hopkins University   (United States)

Author keywords

Biomarkers; Breast cancer; Gene expression analysis; Genomics; MammaPrint; Personalized medicine; Prediction; Reproducible research; Top scoring pair

Indexed keywords

GLUTATHIONE TRANSFERASE M3; SOMATOMEDIN BINDING PROTEIN 5;

3 OXOACID COENZYME A TRANSFERASE 1; ACCURACY; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CANCER SURVIVAL; CELL DIVISION CYCLE ASSOCIATED 7 GENE; CONTIG40831 RC GENE; CONTROLLED STUDY; DENTICLELESS E3 UBIQUITIN PROTEIN LIGASE HOMOLOG GENE; DISEASE FREE SURVIVAL; G PROTEIN COUPLED RECEPTOR 180 GENE; GENE; GENE EXPRESSION PROFILING; GENETIC ALGORITHM; GENOMICS; GLUTATHIONE S TRANSFERASE MU 3 GENE; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA Z POLYPEPTIDE GENE; HRAS LIKE SUPPRESSOR GENE; HUMAN; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN 5 GENE; LGP2 GENE; MAJOR CLINICAL STUDY; MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE GENE; MEMBRANE SPANNING 4 DOMAIN SUBFAMILY A MEMBER 7 GENE; RECEIVER OPERATING CHARACTERISTIC; REPLICATION FACTOR C 4 GENE; REPRODUCIBILITY; RETICULON 4 RECEPTOR LIKE 1 GENE; SENSITIVITY AND SPECIFICITY; SMALL EDRK RICH FACTOR 1A GENE; TOP SCORING PAIR; UBIQUITIN CARBOXYL TERMINAL HYDROLASE L5 GENE;

BREAST NEOPLASMS; COHORT STUDIES; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; HUMANS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SOFTWARE;

EID: 84877806149     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-14-336     Document Type: Article

References (34)

1. Marchionni L, Wilson RF, Wolff AC, Marinopoulos S, Parmigiani G, Bass EB, Goodman SN. Systematic review: gene expression profiling assays in early-stage breast cancer. Ann Intern Med 2008, 148(5):358-369. 10.7326/0003-4819-148-5-200803040-00208, 18252678.
2. Paik S. Is gene array testing to be considered routine now?. Breast 2011, 20(Suppl 3):S87-S91.
3. Glas AM, Floore A, Delahaye LJ, Witteveen AT, Pover RC, Bakx N, Lahti-Domenici JS, Bruinsma TJ, Warmoes MO, Bernards R. Converting a breast cancer microarray signature into a high-throughput diagnostic test. BMC Genomics 2006, 7:278. 10.1186/1471-2164-7-278, 1636049, 17074082.
4. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004, 351(27):2817-2826. 10.1056/NEJMoa041588, 15591335.
5. Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 2009, 27(8):1160-1167. 10.1200/JCO.2008.18.1370, 2667820, 19204204.
6. Loi S, Haibe-Kains B, Desmedt C, Lallemand F, Tutt AM, Gillet C, Ellis P, Harris A, Bergh J, Foekens JA. Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. J Clin Oncol 2007, 25(10):1239-1246. 10.1200/JCO.2006.07.1522, 17401012.
7. Ma XJ, Salunga R, Dahiya S, Wang W, Carney E, Durbecq V, Harris A, Goss P, Sotiriou C, Erlander M. A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer. Clin Cancer Res 2008, 14(9):2601-2608. 10.1158/1078-0432.CCR-07-5026, 18451222.
8. IOM (Institute of Medicine) Evolution of translational Omics: lessons learned and the path forward 2012, Washington, D.C: The National Academy Press, IOM (Institute of Medicine).
9. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415(6871):530-536. 10.1038/415530a, 11823860.
10. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002, 347(25):1999-2009. 10.1056/NEJMoa021967, 12490681.
11. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst 2005, 97(16):1180-1184. 10.1093/jnci/dji237, 16106022.
12. Leek JT, Peng RD, Anderson RR. Personalized medicine: keep a way open for tailored treatments. Nature 2012, 484(7394):318.
13. Baggerly K. Disclose all data in publications. Nature 2010, 467(7314):401.
14. Peng RD. Reproducible research and biostatistics. Biostatistics 2009, 10(3):405-408. 10.1093/biostatistics/kxp014, 19535325.
15. Peng RD, Dominici F, Zeger SL. Reproducible epidemiologic research. Am J Epidemiol 2006, 163(9):783-789. 10.1093/aje/kwj093, 16510544.
16. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001, 29(4):365-371. 10.1038/ng1201-365, 11726920.
17. Goozner M. Duke scandal highlights need for genomics research criteria. J Natl Cancer Inst 2011, 103(12):916-917. 10.1093/jnci/djr231, 21693754.
18. Peng RD. Reproducible research in computational science. Science 2012, 334(6060):1226-1227.
19. Buyse M, Loi S, van't Veer L, Viale G, Delorenzi M, Glas AM, d'Assignies MS, Bergh J, Lidereau R, Ellis P. Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst 2006, 98(17):1183-1192. 10.1093/jnci/djj329, 16954471.
20. Geman D, d'Avignon C, Naiman DQ, Winslow RL. Classifying gene expression profiles from pairwise mRNA comparisons. Stat Appl Genet Mol Biol 2004, 3:Article 19.
21. Leek JT. The tspair package for finding top scoring pair classifiers in R. Bioinformatics 2009, 25(9):1203-1204. 10.1093/bioinformatics/btp126, 2672632, 19276151.
22. Brazma A, Kapushesky M, Parkinson H, Sarkans U, Shojatalab M. Data storage and analysis in ArrayExpress. Methods Enzymol 2006, 411:370-386.
23. A simple and reproducible breast cancer prognostic test. http://luigimarchionni.org/breastTSP.html.
24. Ihaka R, Gentleman R. R: A language for data analysis and graphics. J Comput Graph Stat 1996, 5:299-314.
25. Tan AC, Naiman DQ, Xu L, Winslow RL, Geman D. Simple decision rules for classifying human cancers from gene expression profiles. Bioinformatics 2005, 21(20):3896-3904. 10.1093/bioinformatics/bti631, 1987374, 16105897.
26. Price ND, Trent J, El-Naggar AK, Cogdell D, Taylor E, Hunt KK, Pollock RE, Hood L, Shmulevich I, Zhang W. Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas. Proc Natl Acad Sci U S A 2007, 104(9):3414-3419. 10.1073/pnas.0611373104, 1805517, 17360660.
27. Weichselbaum RR, Ishwaran H, Yoon T, Nuyten DS, Baker SW, Khodarev N, Su AW, Shaikh AY, Roach P, Kreike B. An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer. Proc Natl Acad Sci U S A 2008, 105(47):18490-18495. 10.1073/pnas.0809242105, 2587578, 19001271.
28. Raponi M, Lancet JE, Fan H, Dossey L, Lee G, Gojo I, Feldman EJ, Gotlib J, Morris LE, Greenberg PL. A 2-gene classifier for predicting response to the farnesyltransferase inhibitor tipifarnib in acute myeloid leukemia. Blood 2008, 111(5):2589-2596. 10.1182/blood-2007-09-112730, 18160667.
29. Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, Snyder EY, Sulman EP, Anne SL, Doetsch F, Colman H. The transcriptional network for mesenchymal transformation of brain tumours. Nature 2010, 463(7279):318-325. 10.1038/nature08712, 20032975.
30. van Belle G, Fisher LD, Heagerty PJ, Lumley T. Biostatistics: A methodology for the health sciences 2004, Hoboken, New Jersey: John Wiley and Sons, 2.
31. Tian S, Roepman P, Van't Veer LJ, Bernards R, de Snoo F, Glas AM. Biological functions of the genes in the mammaprint breast cancer profile reflect the hallmarks of cancer. Biomark Insights 2010, 5:129-138. 2999994, 21151591.
32. Zhang G, Gibbs E, Kelman Z, O'Donnell M, Hurwitz J. Studies on the interactions between human replication factor C and human proliferating cell nuclear antigen. Proc Natl Acad Sci U S A 1999, 96(5):1869-1874. 10.1073/pnas.96.5.1869, 26703, 10051561.
33. Ohta S, Shiomi Y, Sugimoto K, Obuse C, Tsurimoto T. A proteomics approach to identify proliferating cell nuclear antigen (PCNA)-binding proteins in human cell lysates. Identification of the human CHL12/RFCs2-5 complex as a novel PCNA-binding protein. J Biol Chem 2002, 277(43):40362-40367. 10.1074/jbc.M206194200, 12171929.
34. Jascur T, Fotedar R, Greene S, Hotchkiss E, Boland CR. N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) triggers MSH2 and Cdt2 protein-dependent degradation of the cell cycle and mismatch repair (MMR) inhibitor protein p21Waf1/Cip1. J Biol Chem 2011, 286(34):29531-29539. 10.1074/jbc.M111.221341, 3190993, 21725088.